Literature DB >> 17553479

A CBS haplotype and a polymorphism at the MSR gene are associated with cardiovascular disease in a Spanish case-control study.

Roser Urreizti1, Carla Asteggiano, Maria Antonia Vilaseca, Emili Corbella, Xavier Pintó, Daniel Grinberg, Susana Balcells.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the association of polymorphisms present in genes related to homocysteine (Hcy) metabolism with coronary artery disease (CAD). DESIGN AND METHODS: We examined 8 polymorphisms in the cystathionine beta-synthase (CBS), glutamate carboxypeptidase II (GCPII), methionine synthase (MS), methionine synthase reductase (MSR) and methylenetetrahydrofolate reductase (MTHFR) genes in 140 CAD patients and 113 controls, by means of Chi-square, logistic regression, ANOVA and the Mann-Whitney U test.
RESULTS: The c.66 G allele of MSR conferred an odds-ratio for CAD of 1.76 (95% CI 1.12-2.77), while a CBS haplotype [c.699C-c.844wt-c.1080C] was found over-represented in CAD [OR of 2.16 (1.29-3.63)].
CONCLUSIONS: Our results not only highlight the involvement of the MSR and CBS genes in the etiology of cardiovascular disease, but also emphasize the strength of haplotype analyses in association studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553479     DOI: 10.1016/j.clinbiochem.2007.04.008

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  4 in total

1.  Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: the antihypertensive and lipid lowering to prevent heart attack trial (ALLHAT-LLT).

Authors:  Karen L Margolis; Kay Dunn; Lara M Simpson; Charles E Ford; Jeff D Williamson; David J Gordon; Paula T Einhorn; Jeffrey L Probstfield
Journal:  Am Heart J       Date:  2009-12       Impact factor: 4.749

2.  Interactions between the single nucleotide polymorphisms in the homocysteine pathway (MTHFR 677C>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study.

Authors:  Anke-Hilse Maitland-van der Zee; Amy Lynch; Eric Boerwinkle; Donna K Arnett; Barry R Davis; Catherine Leiendecker-Foster; Charles E Ford; John H Eckfeldt
Journal:  Pharmacogenet Genomics       Date:  2008-08       Impact factor: 2.089

3.  Polymorphisms in mitochondrial genes and prostate cancer risk.

Authors:  Liang Wang; Shannon K McDonnell; Scott J Hebbring; Julie M Cunningham; Jennifer St Sauver; James R Cerhan; Grazia Isaya; Daniel J Schaid; Stephen N Thibodeau
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

4.  The association between the 844ins68 polymorphism in the CBS gene and breast cancer.

Authors:  Martha Patricia Gallegos-Arreola; Luis Eduardo Figuera-Villanueva; Adriana Ramos-Silva; Efraín Salas-González; Ana María Puebla-Pérez; Valeria Peralta-Leal; José Elías García-Ortiz; Ingrid Patricia Dávalos-Rodríguez; Guillermo Moisés Zúñiga-González
Journal:  Arch Med Sci       Date:  2014-12-22       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.